Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,551,814 papers from all fields of science
Search
Sign In
Create Free Account
oxdralazine
Known as:
3-(bis(2-hydroxyethyl)amino)-6-hydrazinopyridazine
, 6-(bis(2-hydroxyethyl)amino)-3(2H)-pyridazinone, hydrazone
, hydrazinopyridazine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Ethanolamines
Pyridazines
L 6150
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Metal binding by pharmaceuticals. Part 4. A comparative investigation of the interaction of metal ions with hydralazine, prizidilol and related compounds
H. Al-Falahi
,
P. M. May
,
A. M. Roe
,
R. Antony Slater
,
W. Trott
,
David R. Williams
Agents and Actions
2005
Corpus ID: 33977630
The metal complexing properties of two antihypertensive drugs, hydralazine (1-hydrazinophthalazine) and prizidilol (a…
Expand
2004
2004
Changes in renal function induced by endralazine, a new antihypertensive drug
E. Wegmüller
,
F. Reubi
European Journal of Clinical Pharmacology
2004
Corpus ID: 26585767
SummaryThe effects of endralazine, a new antihypertensive hydrazinopyridazine derivative, on heart rate, mean blood pressure (mBP…
Expand
1990
1990
Influence of acetylator status on the haemodynamic effects and pharmacokinetics of cadralazine in healthy subjects.
P. Brunel
,
J. Lecaillon
,
T. Guyene
,
P. Imhof
,
J. Ménard
British Journal of Clinical Pharmacology
1990
Corpus ID: 34722310
1. Cadralazine is a new antihypertensive agent which causes peripheral vasodilation, probably mediated by a hydrazinopyridazine…
Expand
1983
1983
Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.
B. Karlberg
,
R. Larsson
,
+5 authors
A. Flock
European Journal of Clinical Pharmacology
1983
Corpus ID: 9170890
After an initial placebo period of four weeks 24 patients with primary hypertension were treated with prizidilol, a…
Expand
1983
1983
A Crossover Trial of Oxdralazine in Hypertension
A. Salvadeo
,
G. Villa
,
O. Segagni
,
F. Galli
,
D. Criscuolo
Journal of clinical pharmacology
1983
Corpus ID: 27918625
Abstract: Twenty‐nine moderate and severe essential hypertensive patients completed a crossover study aimed at evaluating…
Expand
1980
1980
Hemodynamic effects of oxdralazine and hydralazine in hypertension
R. Moskowitz
,
J. Cohn
Clinical pharmacology and therapy
1980
Corpus ID: 30301807
Oxdralazine, a pyridazine shown to induce prolonged arteriolar dilation in animals, was given orally in doses of 15 to 30 mg to 7…
Expand
1980
1980
Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
W. Kirch
,
C. von Gizycki
International journal of clinical pharmacology…
1980
Corpus ID: 10186282
1979
1979
Oxdralazine, a New Peripheral Vasodilator, Combined With Propranolol and Hydrochlorothiazide: A Rational Approach to Antihypertensive Treatment
E. Bartoli
,
R. Faedda
,
S. Arras
,
A. Satta
,
G. Soggia
Journal of clinical pharmacology
1979
Corpus ID: 31875529
Forty-three patients suffering from hypertension of different origin (chronic renal failure, gout, or idiopathic) were treated…
Expand
1979
1979
Long-term study of oxdralazine in hypertensive patients.
A. Salvadeo
,
G. Villa
,
S. Segagni
,
D. Criscuolo
Arzneimittel-Forschung
1979
Corpus ID: 9660939
56 moderate and severe hypertensive patients entered an open long-term trial aimed at evaluating the efficacy and tolerability of…
Expand
1978
1978
Role of physical factors in the acute changes in renal function elicited by antihypertensive drugs
F. Reubi
European Journal of Clinical Pharmacology
1978
Corpus ID: 23899128
SummaryAn analysis of the correlations between acute changes in blood pressure and renal function elicited by antihypertensive…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE